Tradition Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Tradition Wealth Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$343.0 - $410.68 $3,430 - $4,106	10 Added 2.5%	410 $167,000
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $338 - $362	1 Added 0.25%	400 $139,000
Q2 2023 Aug 14, 2023	BUY	$314.42 - $351.91 $314 - $351	1 Added 0.25%	399 $140,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $2,549 - $2,907	9 Added 2.31%	398 $125,000
Q4 2022 Feb 03, 2023	BUY	$285.76 - $321.48 $571 - $642	2 Added 0.52%	389 $112,000
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $98,304 - $109,685	359 Added 1282.14%	387 $112,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $18,139 - $20,299	-100 Reduced 78.13%	28 $5,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $26,497 - $35,339	128 New	128 $30,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Tradition Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tradition Wealth Management, LLC with notifications on news.